TransNusa Increases Scheduled Flight Frequency to Twice Daily ACN Newswire

TransNusa Increases Scheduled Flight Frequency to Twice Daily

JAKARTA, June 2, 2025 - (ACN Newswire via SeaPRwire.com) - South East Asia’s first holistic premium service airline, PT TransNusa Aviation Mandiri, is further strengthening its presence in Perth by increasing the frequency of its scheduled flights for its Bali – Perth route to twice daily or 14 times a week from its current 7 times a week.TransNusa Group Chief Executive Officer, Datuk Bernard Francis said that sales of tickets for the additional flights started yesterday.“We will increase the frequency of flight in two phases. First phase will see TransNusa’s scheduled flights increasing from 7 times weekly to 11 times weekly. The additional four flights will be scheduled for Wednesday, Thursday, Friday and Sunday,” he said, adding that the first phase will begin on July 2.With regard to the second phase, Datuk Francis said that TransNusa will increase its scheduled flight frequency from 11 times weekly to 14 times weekly starting July 18.This announcement comes a little more than two months after TransNusa successfully launch its scheduled flights to Perth from its base in Bali on March 20, 2025.Datuk Francis explained that TransNusa has plans to further strengthen and enhance its offerings to passengers in a bid to increase passengers’ comfort on all its flights.“The move to enhance our customer comfort is part of our plan to grow TransNusa as a secure and caring brand in line with our Premium Service Carrier status,” Datuk Francis explained.TransNusa, which has been operating its international flights as a Premium Service Airline and its domestic routes as a Low-Cost Carrier (LCC), was recently given the green light by the Indonesian Aviation Authority to operate as a Premium Service Airline in their domestic market as well.This success comes on the back off its value-added services such as all the airline’s planes are configured with less seats than that of a LCC, the airline provides refund and unlimited flight changes for its Seat Plus and Flexi-Pro tickets, respectively, among others. TransNusa passengers also enjoys a minimum check-in baggage allowance of 20kg and a hand carry baggage allowance of 7kg.Sale of tickets for TransNusa’s scheduled flight are currently priced from IDR1.699.000 onwards, AUD156 onwards, CNY740 onwards, USD110 onwards, and MYR487 onwards. Potential passengers can purchase the tickets at transnusa.co.id or any secure Online Travel Agents (OTAs). For passengers who purchase tickets from OTAs, they can check-in at transnusa.co.id.TransNusa’s additional scheduled flight, 8B 082 (DPS-PER), will depart at 12.55pm from the I Gusti Ngurah Rai International Airport and arrive at Perth Airport at 16.55pm on July 1 onwards. While TransNusa flight, 8B 083 (PER-DPS), will depart Perth Airport at 18.05pm and arrived at the I Gusti Ngurah Rai International Airport at 21.50pm.TransNusa will continue to operate its current scheduled flight, 8B 080 (DPS-PER), which departs Bali at 09.10am from I Gusti Ngurah Rai International Airport and arrive the Perth Airport at 12.50pm. The flight, 8B 081 (PER-DPS), will depart Perth Airport at 13.35pm and arrive at I Gusti Ngurah Rai International Airport in Bali on 17.20pm.TransNusa will be utilising its Airbus A320 that has a seat capacity of 174 for this international route that has a 3 hours and 40 minutes flight duration.Apart from the Bali-Perth international route, TransNusa also operates scheduled flights from its base in Bali to Guangzhou, China.Datuk Francis said that TransNusa has the shortest transit time of a maximum of 2 hours between the scheduled arrival of its flights from Perth to Bali and from Bali to Guangzhou.“For West Australians looking for a more adventurous vacation, they can spend some time in Bali and jet across to Guangzhou to experience places such as Gulong Gorge skywalk glass bridge,” Datuk Francis added.On TransNusa’s Premium Service Carrier product offerings, Datuk Bernard stressed that for its international flights, TransNusa not only provide premium services with competitive ticket prices, but the airline also has attractive product bundles called SEAT, SEAT-PLUS and FLEXI-PRO.“For the highest package, FLEXI-PRO, we provide more complete services such as free baggage 30kgs, free to choose seats, free food, and drinks, priority at check-in and boarding. In addition, TransNusa also provides its FLEXI-PRO passengers with the ability to be able to change their flight schedule without restrictions and obtain refund when needed."We are committed to providing affordable and competitive ticket prices, while still providing premium services to our customers.” concluded Datuk Bernard.DATUK BERNARD FRANCIS… TransNusa to focus on passengers’ needs and comfortAbout TransNusaEstablished in 2005, TransNusa started its operation by providing chartered flights. It began its commercial flights in 2011. After ceasing operations due to the Covid-19 pandemic, TransNusa relaunched itself in 2021 as a low-cost airline in its domestic market. In 2023, TransNusa introduced a new business model making it the first Premium Service Airline in the region. The new business model will apply only to its international routes. TransNusa introduced its first international route in April, 2023. The airline introduced its Jakarta – Kuala Lumpur round trip route and had its maiden flight on April 14, followed by the Jakarta – Singapore route on November 20, 2023. After which, the airline successfully launched three more new international routes by the end of 2023. The airline is currently based in Jakarta Soekarno-Hatta International Airport. Passengers can book their flights on the TransNusa website (www.transnusa.co.id), through authorized travel agents in Singapore and Indonesia, or by contacting the airline's customer service centre at, +62216310888. For the Singaporean market, passengers can contact TransNusa’s General Sales Agent, Chariot Travels Pte Ltd, at +65 86602719.Media ContactTrina Thomas Rajtrina@myqaseh.org +60124992672 (watsapp) Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Hola Prime Launches Performance Coaching Initiative to Tackle the #1 Barrier to Trader Success: The Mind ACN Newswire

Hola Prime Launches Performance Coaching Initiative to Tackle the #1 Barrier to Trader Success: The Mind

NEW YORK, May 30, 2025 - (ACN Newswire via SeaPRwire.com) - In proprietary trading, success is often measured in percentages and profit curves. But behind every chart is a human being, and according to Hola Prime, one of the fastest-growing prop firms globally, that human element is the most overlooked edge in trading.To address this critical gap, Hola Prime has launched a new Performance Coaching Initiative, bringing psychological resilience, discipline, and emotional intelligence to the forefront of trader development. The firm has onboarded two accomplished professionals - Lara Leon and Stanislava Puac Jovanovic - and aims to solve what the firm calls "the #1 barrier to consistent trader performance: the mind.""We've funded traders all around the globe, and the pattern is clear - strategy alone doesn't make you consistent. Psychology does," said Somesh Kapuria, CEO of Hola Prime. "Our Performance Coaching Initiative is built to tackle that challenge head-on."Prop firms often compete on speed, funding, and payouts. But Hola Prime is betting that the next evolution of trading support won't be just financial - it will be behavioral.Whether it's FOMO, overtrading, revenge trading, or the inability to recover after a loss, psychological missteps are responsible for more failed trading careers than poor technical knowledge. Despite this, few firms invest in helping traders build emotional resilience, daily structure, and self-awareness.Hola Prime's new program is designed to fill that void, offering one-on-one performance coaching, guided psychological routines, and mindset-focused support for its funded traders. The goal is not short-term motivation, but long-term, measurable consistency.Globally Renowned Performance CoachesTo drive the initiative, Hola Prime has onboarded:Lara Leon, a performance coach with over a decade of experience in psychology and active trading. A psychotherapist by training and a trader by passion, Lara blends cognitive insight with technical market expertise - covering order flow, volume profiles, and multi-timeframe analysis. Her coaching focuses on building internal discipline, trade journaling, and walking through emotional pitfalls with clarity and structure.Stanislava Puac Jovanovic, a psychologist and life coach with over 15 years of experience across education, coaching, and systemic psychotherapy. Certified in CBT, REBT, assertive communication, mindfulness, and NLP, she brings a holistic understanding of emotional regulation, stress management, and performance psychology - tools essential for thriving in high-pressure trading environments.Both coaches will offer traders structured frameworks to improve risk management, build sustainable habits, and enhance decision-making under stress.This initiative marks a shift in how prop firms support their traders - not just with capital, but with cognitive and emotional infrastructure.For Hola Prime, performance coaching is not an add-on - it's a foundational investment in trader longevity. At a time when retail traders face increased market volatility, higher expectations, and rapid information flow, support is more essential than ever."The future of prop trading belongs to firms that understand one truth," said Kapuria. "The edge isn't just in the market. It's in the mind."Social LinksInstagram: https://www.instagram.com/holaprime_global/ YouTube: https://www.youtube.com/channel/UCtVEJa1Ml132Be7tnk-DjeQ LinkedIn: https://www.linkedin.com/company/hola-prime/?viewAsMember=true X: https://x.com/HolaPrimeGlobal Discord: https://discord.gg/TJ7TcHPXBf Quora: https://www.quora.com/profile/HolaPrime/ Reddit: https://www.reddit.com/user/HolaPrime/ Medium: https://medium.com/@social_46267 Media ContactCompany: Hola PrimeContact: Media TeamWebsite: https://holaprime.com/SOURCE: Hola Prime Copyright 2025 ACN Newswire via SeaPRwire.com.
More
從項目攻堅到生態賦能:一文看懂五菱汽車無人駕駛的進化密碼 ACN Newswire

從項目攻堅到生態賦能:一文看懂五菱汽車無人駕駛的進化密碼

香港, 2025年5月30日 - (亞太商訊 via SeaPRwire.com) - 2024年,隨著國家政策頻出和以北京、上海為代表的20多家應用試點城市的確定,基於網聯的"車路雲一體化"自動駕駛路徑正逐漸成為業界共識。在自動駕駛應用場景熱火朝天擴容時,五菱汽車(00305.HK)悄然完成了一場從技術追趕者到生態構建者的蛻變。其無人駕駛業務的發展軌跡,不僅折射出中國汽車產業智能化轉型的縮影,更揭示了傳統車企向科技企業躍遷的底層邏輯。 一、管理進化:從項目孵化到成立科技企業2016年12月,為推動科技創新孵化和成果轉化落地,五菱汽車正式啟動菱動科技企業孵化器建設,定位為汽車產業領域的專業化垂直型"雙創"載體,重點聚焦汽車新四化、智能製造和汽車後市場領域,構建起全流程創新孵化鏈條,助推創新項目與技術、研發、生產、市場和供應鏈無縫鏈接,加速成果轉化及產業化落地。2018年,低速無人駕駛項目獲得菱動科技企業孵化器10萬元創新種子基金支持,由此成立項目組,開始自主研發無人駕駛車輛。隨著產品原型開發落地和場景驗證完成,五菱汽車在原有項目組基礎上,不斷完善人員配置和人才梯隊建設,構建起"產品研發-示範運營-製造-市場-售後"全流程管理架構和保障機制,全流程管理架構和保障機制,並注入充足研發運營資金,以支持無人駕駛業務逐漸孵化壯大和產品陸續推出。2025年,五菱汽車著手成立無人駕駛開發和運營科技企業,以公司化獨立運營,集中技術和創新資源、提升決策效率、力推業務起飛。二、定位升級:從單一產品到多元化方案輸出2020年11月,五菱無人物流車在專用車廠投入使用,通過配備的GPS 定位系統、視覺傳感器、慣導系統和車端無線模塊,準確運送白車身等產品到各個工位。隨著技術積累,五菱汽車自主研製出前後橋、EPB、EHB等核心底盤零部件,車規級線控底盤,以及菱御智駕系統;陸續推出移動充電機器人、無人駕駛巡邏車、無人駕駛觀光/接駁車(五菱太空艙、無人駕駛觀光車)、智能跟隨高爾夫球車、無人駕駛教學車等產品,構建起無人充電、無人觀光接駁、無人物流等多樣化解決方案。五菱太空艙,搭載自主研發的菱御2.0智能駕駛系統,配備三維立體的多重融合感知系統及集成平台化的線控底盤,具備遠程監控、智能交互等功能,適用於特定區域的接待、觀光、通勤等應用場景,已交付柳鋼集團防城港基地和武漢理工大學投入使用。車規級線控底盤是五菱汽車無人駕駛業務的核心基盤,五菱汽車掌握線控底盤核心技術及控制系統,實現了技術模組塊化,開放通用協議,可幫助快速實現產品二次開發和整車開發,實現1+N配套功能型上裝,形成"平台+生態"的商業模式。三、場景突破:從封閉園區到多場景服務網絡早期五菱汽車的無人駕駛佈局集中於廠區物流場景,產品主要用途為滿足廠區內生產所需的零部件配送。隨後,五菱汽車針對新能源汽車高速發展與充電場站建設增容成本高且潮汐現象明顯的場景,推出4款多容量支持"穀充峰放"和V2G技術等多種充電模式、可實現電網調峰的移動充電機器人,解決電網調平壓力及新能源汽車找樁難問題,將應用場景拓展到電網台區、景區、商圈、住宅區、高速公路、服務區和機場等區域。截止2024年底,移動儲能充電車已在南寧、天津、寧波、上海和柳州等多地投放,並出口至台灣、東南亞、歐洲等海外地區;累計投放數百台,實現產值約2100萬。四、資源重構:從企業單點突破到產業生態共建智能駕駛業務孵化之初,資源均依賴五菱汽車單點導入,後逐步引入蘑菇車聯、摩菱科技等合作夥伴,共同聚焦智能網聯汽車開發和無人駕駛示範運營。此外,主力產品線控底盤平台已接入20餘家生態夥伴,衍生出充電機器人、巡邏車等10餘種車型,逐步構建起"線性底盤-整車產品-場景運營"的無人駕駛產業生態。結語2025年,五菱汽車將繼續聚焦線控底盤及核心零部件、無人充電、無人物流、無人觀光和接駁場景,提升線控底盤品質,豐富整車產品譜系,為市場提供系統化解決方案,賦能用戶美好生活。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
The PropertyGuru Asia Property Awards (Middle East) return for 2025 edition with inaugural Dubai launch ACN Newswire

The PropertyGuru Asia Property Awards (Middle East) return for 2025 edition with inaugural Dubai launch

‘ASIA CONNECT: DUBAI’ DISCUSSES OPPORTUNITIES FOR ASIAN REAL ESTATE INVESTMENT IN THE LEAD UP TO THE SECOND EDITION OF THE AWARDS IN THE MIDDLE EASTDUBAI, May 30, 2025 - (ACN Newswire via SeaPRwire.com) - PropertyGuru, Southeast Asia’s leading property technology company, today launched the latest edition of its real estate awards programme in the Middle East from Dubai, expanding its reach into the region’s thriving markets.Following a successful debut in 2024, the PropertyGuru Asia Property Awards (Middle East) return for their second edition, providing a widely respected, trusted platform for showcasing the achievements and innovations of developers in the region.The PropertyGuru Asia Property Awards (Middle East) return for their second edition with the inaugural “Asia Connect: Dubai” launch eventThe timeline for the 2025 awards season was revealed today during the “Asia Connect: Dubai” event at the Conrad Dubai Hotel, with distinguished guests and organisers in attendance. The 2025 PropertyGuru Asia Property Awards (Middle East) programme will conclude in an international luncheon and presentation ceremony at The Athenee Hotel, a Luxury Collection Hotel, Bangkok during PropertyGuru Week in December 2025.Key dates for the 2025 Awards are:19 September 2025 – Entries Close1-3 October 2025 – Site Inspections17 October 2025 – Final Judging12 December 2025 – International Luncheon and Awards Ceremony in Bangkok, Thailand12 December 2025 – Regional Grand Final Gala Dinner and Awards Presentation in Bangkok, ThailandEnduring global appealAsia Connect: Dubai served as an opportunity for stakeholders in the real estate industry to network and showcase the enduring global appeal of properties in the Middle East to investors.The premier gathering comes as luxury real estate markets like Dubai and Abu Dhabi continue to attract high-net-worth individuals from around the world, according to research by Property Report by PropertyGuru, the official magazine of the Awards. Strategic government initiatives and investor-friendly policies have bolstered property markets and attracted sustained foreign investment into the region. Asia Connect: Dubai Panel DiscussionA panel discussion, “Opening the Doors for Asian Real Estate Investors in the Middle East,” drew esteemed speakers such as Fiona Juan Wang, senior manager for training and development at DAMAC Properties; Lavin Nalinababu, director for business consultancy at HLB HAMT; and Stephen Oehme, director of Quantum Analysis Pte Ltd Singapore and member of the PropertyGuru Asia Property Awards (Middle East) judging panel.Mr Jules Kay, the general manager of PropertyGuru Asia Property Awards, giving his speech about ‘Gold Standard’ in the region’s real estate.Jules Kay, general manager of PropertyGuru Asia Property Award and Events, was also in attendance, reiterating the programme’s pursuit of excellence in 2025.He said: “We are happy to introduce the PropertyGuru Asia Property Awards to the Middle East to showcase one of the world’s most dynamic property markets to discerning investors and property seekers across Asia. With its appealing economic profile, attractive lifestyle choices, and developers' commitment to considering the environment, Middle Eastern property offers far more than pure investment. This year, we aim to raise the standard of real estate in a region already defined by excellence, with its ambitious skylines, megaprojects, and sustainability goals. Through the Awards, we encourage the innovators, pioneers, and leaders of this aspirational property market to showcase their towering achievements to the rest of Asia.”Coco Liu, chief growth officer of HLB Global, came on behalf of the award-winning network of independent professional accounting firms and business advisers.Leveraging upon its experience in monitoring award systems around the world, HLB is entrusted with overseeing the entire judging process of the PropertyGuru Asia Property Awards (Middle East). Working with organisers of the PropertyGuru Asia Property Awards, HLB HAMT will supervise the selection process and ensure its fairness, transparency, and credibility.Informing property seekersWith an expanded roster of categories for 2025, the PropertyGuru Asia Property Awards (Middle East) are poised to inform property seekers in other Asian countries of more choices in quality real estate.New categories include Best Township Developer; Best Community Developer; Best Mega Township Development; Best Completed Mixed Use Development; Best Oceanview Condo Development; Best Oceanview Housing Development; Best Multigeneration Living Condo Development; Best Multigeneration Living Housing Development; Best Renovated Residential Development; Best Renovated Commercial Development; and Best Smart Commercial Development.The PropertyGuru Asia Property Awards (Middle East) are part of the PropertyGuru Asia Property Awards series. Established in Thailand in 2005, the series marks its 20th edition this year, with a presence now spanning 13 countries and counting across Asia Pacific.Winners of this year’s Awards in the Middle East may qualify to compete for the Best in Asia titles at the 20th PropertyGuru Asia Property Awards Grand Final in Bangkok in December 2025. Last year, Oud Real Estate Company triumphed with the Best Mixed Use Developer (Asia) title at the 19th PropertyGuru Asia Property Awards Grand Final, following wins during the inaugural PropertyGuru Asia Property Awards (Middle East).The 2025 PropertyGuru Asia Property Awards (Middle East) are supported by official property portal PropertyGuru; official magazine Property Report by PropertyGuru; and official supervisor HLB.For more information, email awards@propertyguru.com or visit the official website: AsiaPropertyAwards.com.ABOUT PROPERTYGURU ASIA PROPERTY AWARDS:PropertyGuru’s Asia Property Awards, established in 2005, are the region’s most exclusive and prestigious real estate awards programme. The Asia Property Awards are recognised as the ultimate hallmark of excellence in the Asian property sector. Boasting an independent panel of industry experts and trusted supervisors, the Awards have an unparalleled reputation for being credible, ethical, fair, and transparent. In 2025, the Awards series is open to key property markets around the region. The exciting gala events welcome senior industry leaders and top media, as well as reach property agents and consumers via live streaming. Recognising excellence within each Asian market with a variety of categories, including green and sustainable development, each local awards programme will culminate in the PropertyGuru Asia Property Awards Grand Final, which takes place after the PropertyGuru Asia Real Estate Summit during PropertyGuru Week in December 2025. For more information, please visit AsiaPropertyAwards.com.ABOUT PROPERTYGURU GROUP:PropertyGuru is Southeast Asia’s leading1 PropTech company, and the preferred destination for over 31 million property seekers2 to connect with over 50,000 agents monthly3 to find their dream home. PropertyGuru empowers property seekers with more than 2.1 million real estate listings4, in-depth insights, and solutions that enable them to make confident property decisions across Singapore, Malaysia, Thailand, and Vietnam.PropertyGuru.com.sg was launched in Singapore in 2007 and since then, PropertyGuru Group has made the property journey a transparent one for property seekers in Southeast Asia. In the last 17 years, PropertyGuru has grown into a high-growth PropTech company with a robust portfolio including leading property marketplaces and award-winning mobile apps across its core markets. For more information, please visit: PropertyGuruGroup.com; PropertyGuru Group on LinkedIn.(1) Based on SimilarWeb data between January 2024 and June 2024.(2) Based on Google Analytics data between January 2024 and June 2024.(3) Based on data between April 2024 and June 2024.(4) Based on data between January 2024 and June 2024.CONTACTS:General Enquiries:Richard Allan Aquino, Head of Brand & Marketing ServicesM: +66 92 954 4154E: allan@propertyguru.com Media & Partnerships:Piyachanok Raungpaka, Senior Media & Marketing Services ExecutiveM: +66 94 887 5163E: piyachanok@propertyguru.comSales, Nominations, & Sponsorships:Priyamani Srimokla, Account Manager, Awards SponsorshipM: +66 85 440 1655E: priya@propertyguru.comSales, Nominations, & Sponsorships:Kai Lok Kwok, Solutions ManagerM: +66 97 117 8595E: kai@propertyguru.com Copyright 2025 ACN Newswire via SeaPRwire.com.
More
MODONG Coffee Proudly Sponsors “G-DRAGON 2025 WORLD TOUR  [Ubermensch] IN TAIPEI, presented by KGI FINANCIAL GROUP” as Official Sponsor ACN Newswire

MODONG Coffee Proudly Sponsors “G-DRAGON 2025 WORLD TOUR [Ubermensch] IN TAIPEI, presented by KGI FINANCIAL GROUP” as Official Sponsor

HONG KONG, May 29, 2025 - (ACN Newswire via SeaPRwire.com) – MODONG Coffee, a leading global health and wellness brand, is proud to announce its sponsorship of G-DRAGON 2025 WORLD TOUR [Übermensch] IN TAIPEI, presented by KGI FINANCIAL GROUP, taking place on July 11 (Fri.) and July 13 (Sun.) at the Taipei Arena. As the Official Sponsor, MODONG Coffee brings an innovative fusion of “Music × MODONG Energy” to create an immersive audiovisual experience for fans. This collaboration marks a strategic milestone in MODONG Coffee’s youth-centric expansion, advancing its “IP + Scenarios + New Retail” ecosystem.As one of Asia's most influential music IPs, G-DRAGON’s upcoming tour, themed "Übermensch", symbolizes his groundbreaking interpretation of art and self-expression. As an Official Sponsor, MODONG Coffee joins forces with Samsung, ADATA Technology, and other brands to deliver an immersive experience, seamlessly blending stunning visuals with exceptional music for the audience. As the flagship product of Star Plus Legend's new retail business, MODONG Coffee has established a leading position in China’s bulletproof drink market since its launch in 2019 with its differentiated product positioning. According to China Insights Consultancy, MODONG coffee has ranked first in the bulletproof drink market by GMV in the PRC for five consecutive years (2020-2024). As of 2024, the cumulative sales of MODONG coffee have reached 100 million cups. That same year, MODONG brand and its products earned multiple prestigious certifications, including “a high profile brand in Jiangsu province” and “the iSEE list of top 100 innovative brands”, further solidifying its market competitiveness.Additionally, MODONG Coffee has deeply integrated with the phenomenal variety show IP "J-Style Trip", achieving "traffic-to-sales conversion" through celebrity-driven marketing and scenario-based campaigns. This strategy drove a 360% year-on-year sales surge in its debut year, propelling Star Plus Legend’s net profit to soar 233% YoY. To meet evolving consumer demands, MODONG Coffee underwent a brand upgrade in 2025, launching the MODONG MAGIC series—Sicilian Lemon Coffee and Cactus Black Coffee—under the concept "A Cup On-the-Go: Crafting Magic for Healthy Living". The brand aims to pioneer a new MODONG lifestyle rooted in low-carb diets and scientific fitness, fostering healthier habits and redefining the relationship between nutrition and wellness. To amplify brand influence, MODONG MAGIC became the exclusive title sponsor of "J-Style Trip Season 3". The show has aired nine episodes to date, dominating CSM71-city provincial satellite TV ratings with nine consecutive time-slot No.1 rankings. It generated 298 trending topics and over 2.9 billion impressions across platforms, igniting widespread social engagement. The support for the "G-DRAGON 2025 WORLD TOUR [Übermensch] IN TAIPEI, presented by KGI FINANCIAL GROUP" represents a key step in MODONG Coffee’s strategic layout of combining “healthy trendy beverages + entertainment.” By leveraging G-DRAGON's global fan appeal and the high popularity of the concert, the brand aims to further expand its influence in the Asia-Pacific market — marking a significant leap for MODONG Coffee from product to brand, and from local to global.Looking ahead, MODONG will remain sharply focused on Gen Z consumers, engaging them through health, music, fashion, and digital art to strengthen its youth-oriented identity. Powered by AI-driven IP innovation, the brand is poised to accelerate the fusion of digital technology and the real economy. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
First patient dosed in YK012 trial-the world’s first TCE therapy for primary membranous nephropathy ACN Newswire

First patient dosed in YK012 trial-the world’s first TCE therapy for primary membranous nephropathy

Key Highlights- Clinical trial to evaluate the safety and efficacy of YK012 in primary membranous nephropathy- Globally, this is the first bispecific CD19-directed CD3 T cell engager immunotherapy for this autoimmune disease- Milder T cell activation than Blincyto and Target cell-dependent T cell activation- Multiple CR cases observed in ongoing r/r NHL Phase Ia trial and r/r ALL Phase Ib/II trialHONG KONG, May 29, 2025 - (ACN Newswire via SeaPRwire.com) – Excyte, a global clinical-stage biotechnology company, announced first patient has been dosed for YK012, the world’s first patient T cell engager that entered into clinical trial for primary membranous nephropathy (pMN). The patient remained well after administration with no adverse reactions witnessed to date.pMN is an autoimmune disease caused by the attack of autoantibodies against podocyte antigens leading to the in situ production of immune complexes. pMN is the most common cause of primary nephrotic syndrome in non-diabetic adults worldwide, accounting for 20% to 37% of affected individuals, and as high as 40% in adults over 60 years of age (1). Currently, 20-30% of pMN cases are resistant to current therapies like rituximab and cyclophosphamide and relapse rates can be high (2).A clear regulatory pathway in this orphan disease in US could make YK012 one of the first approved TCE in the autoimmune space with many other autoimmune and oncology indications to follow. Excyte would file for US investigational new drug (IND) application imminently.The study aims to evaluate the safety, tolerability, and preliminary efficacy of YK012 in PMN patients. Led by Professor Minghui Zhao and Prof Zhao Cui from Peking University First Hospital, the trial is planned to be conducted across multiple centers in China. The clinical trial for this indication in the United States will be collaboratively executed by Excyte and its international partners.“YK012 is a T-cell engaging bispecific antibody targeting both CD19 and CD3, activating T-cell immunity via CD3 while targeting CD19—the most widely expressed tissue-specific marker during B-cell development and thereby enabling B-cell reset. Our data illustrated YK012 mediated significant B cell depletion and have illustrated in current clinical studies extended half-life and limited cytokine release in patients,” said Mr. Andrew Meng, chairman and COO at Excyte. “We look forward to collaborating with regulatory authorities to make YK012 available to this patient population with a high unmet medical need."In December 2024, YK012 obtained Clinical Trial Approval Notice (No. CXSL2400727) from China's National Medical Products Administration (NMPA) and was registered on ClinicalTrials.gov (NCT06982729). With the first patient dosed in pMN, Excyte now has a global presence in autoimmune diseases in additional to oncology indications such as NHL and ALL. Earlier this year, Excyte also secured clinical trial approval for systemic lupus erythematosus (SLE), with Professor Xiaofeng Zeng from Peking Union Medical College Hospital serving as Principal Investigator.About Excyte Biopharma Ltd.Excyte Ltd. was co-founded by Dr Qing’an Yuan and Mr Andrew Meng , biotech industry veterans with decades of antibody engineering experiences. The company has also established a U.S.-based wholly-owned subsidiary, Excyte LLC, forming a dual-engine drug R&D hub spanning China and the U.S. Excyte is dedicated to developing innovative bispecific antibody drugs for hematologic cancers, multiple myeloma, solid tumors, autoimmune diseases, and other conditions. Excyte’s FIST platform and next generation assets possess features such as long-acting, low-toxicity, and high-yield technological innovations. For more information, please visit https://www.iExcyte.com/Business Development ContactYing Liu, liuying@iExcyte.comReferences:1.William G Couser, Primary Membranous Nephropathy, Clin J Am Soc Nephrol. 2017 May 26;12(6):983–997.2.Elham Ahmadian, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed, Mohammadreza Ardalan, Novel treatment options in rituximab-resistant membranous nephropathy patients, International Immunopharmacology, Volume 107, 2022, 108635, ISSN 1567-5769. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Genetec maintains profitability in Q3FY2025 on higher revenue ACN Newswire

Genetec maintains profitability in Q3FY2025 on higher revenue

Key Financial Performance Highlights for Q3FY2025:Group’s total revenue for the quarter jumps to RM75.1 million, with e-mobility and energy storage segments as primary contributors, followed by electronicsPerformance for the quarter supported by prompt execution of outstanding orders from FY2024 and progress on new scopes secured within existing client baseBoth PBT and PAT stand at RM3.2 million for the quarter under reviewGP, PBT, PAT, and PATAMI margins recorded at 11.6%, 4.3%, 4.3% and 1.1% respectivelyBANGI, Malaysia, May 29, 2025 - (ACN Newswire via SeaPRwire.com) - Technology leader in providing turnkey, intelligent manufacturing automation solutions, GENETEC TECHNOLOGY BERHAD (“Genetec” or the “Company”), today announced its financial results for the third quarter ended 31 March 2025 (“Q3FY2025”). The Company reported a jump in their revenue to RM75.1 million, on par with the preceding year-on-year revenue levels, supported by the delivery of outstanding and new orders across its core client base. Gross Profit (“GP”) for the quarter came in at RM8.7 million with both profit before tax (“PBT”) and profit after tax (“PAT”) at RM3.2 million, and profit after tax and minority interests (“PATAMI”) at RM0.8 million. GP, PBT, PAT, and PATAMI margins stood at 11.6%, 4.3%, 4.3% and 1.1% respectively.While the Q3FY2025 revenue marked a return to revenue levels previously seen in FY2024, profit margins and PAT for the quarter fell compared with the previous quarter’s PAT of RM6.3 million. The Company noted that this was due to several deliveries in the quarter involving new scopes which involved one-off, non-recurring expenses. Genetec expects margin to normalise in upcoming quarters.Managing Director and Co-founder of Genetec, Chin Kem Weng commented, “Our top-line performance reflects a pickup in project execution and a healthy pipeline on the back of our ongoing client engagement. The margin dip this quarter is temporary, contributed by one-off expenses tied to the new project scopes and are not recurring. As such, we are confident that we will see a recovery in the margins in the coming quarters as project maturity and margin discipline for the new scopes improve. Genetec’s focus remains on deepening our partnerships with clients in key sectors like electric vehicle (“EV”), automotives, and energy storage, while we continue to seek meaningful diversification.”Amid the ongoing shifts in global trade dynamics and supply chain strategies, Genetec sees structural tailwinds supporting its growth trajectory. As manufacturers reassess production footprints and strengthen operational resilience, there is an upward demand for flexible, cost-competitive and reliable high-quality automation solutions. Genetec’s Malaysia-based production model, combined with a proven international track record, deep technical expertise, and agile manufacturing capabilities, positions the Company well to support clients adapting to these changes.The Company remains focused on deepening its engagement with existing customers while exploring opportunities to broaden its client base. In addition to pursuing new scopes within existing clients’ operations, Genetec has actively participated in several international exhibitions and industry events in recent months, which have generated encouraging business leads. These engagements mark early steps toward potential entry into new industries and segments, in line with the Company’s longer-term strategy to diversify and grow.Genetec is also actively managing its current production load while progressing its EPIC plant expansion, scheduled for completion in early 2026. The new facility will significantly increase floor space and technical capabilities, supporting Genetec’s ability to deliver on multiple high-value projects simultaneously.“We remain focused on timely order execution, quality and cost control, and supporting our clients in a rapidly evolving industrial and technological environment. With steady project momentum, a growing base of client engagements, and strategic expansion into new sectors, we are cautiously optimistic about the road ahead. We believe Genetec is well-positioned to build on this foundation for long-term growth,” Chin concluded.With ongoing execution across key client projects and growing interest from new industries, Genetec continues to position itself as a trusted global partner in automation.About Genetec Technology BerhadGenetec Technology Berhad is a public listed company on the Main Market of Bursa Malaysia Securities Berhad (Stock code: 0104) and a global leader in providing customised, turnkey smart factory automation solutions. With a strong international footprint, it serves a diverse range of industries including electric vehicle (EV), e-mobility and energy storage, automotive, hard disk drives (HDD), consumer electronics, appliances, and pharmaceuticals.For more information please visit: https://genetec.net/. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Naoris Protocol Raises $3M in Strategic Round Led by Mason Labs ACN Newswire

Naoris Protocol Raises $3M in Strategic Round Led by Mason Labs

WILMINGTON, DE, May 29, 2025 - (ACN Newswire via SeaPRwire.com) - Naoris Protocol, the first quantum-resistant blockchain and cybersecurity mesh architecture, has raised $3 million in a strategic funding round led by Mason Labs, that includes Frekaz Group, Level One Robotics and Tradecraft Capital following a six-month technical due diligence process.The round, which includes proceeds from Naoris’s public sale and related allocations, was oversubscribed, prompting the team to open a new institutional raise — now live as of today, Thursday, 29 May.David Carvalho, CEO and Founder of Naoris Protocol, says: “The strong interest we’ve seen from institutions reflects how urgently the industry is beginning to take the threat of quantum computing seriously. This investment supports our mission to future-proof the blockchain ecosystem before these risks become reality.”Mason Labs, a leading venture capital firm focused on infrastructure-grade technologies, conducted a detailed review of Naoris Protocol’s post-quantum trust structure prior to securing the entire VIP allocation.Rain Huan, Founder of Mason Labs, says: “In recent years, cybersecurity issues related to digital assets have become increasingly severe and a serious challenge also faced by Mason Labs as an institution focusing on on-chain asset trading and investment. Naoris Protocol’s groundbreaking infrastructure layer has the potential to effectively mitigate such security risks. If successful, this would represent a substantial advancement for the Web3 ecosystem.”This latest round follows a $31 million fundraise in 2022 backed by Tim Draper, the Holdun Family Office, Expert Doja, Uniera and other institutional investors.Naoris Protocol is led by a team of cybersecurity, defense, and blockchain leaders, including:David Holtzman, former CTO of IBM and architect of the DNS protocolAhmed Réda Chami, Ambassador for Morocco to the EU and former CEO of Microsoft North AfricaMick Mulvaney, former White House Chief of StaffInge Kampenes, former Major General (ret.) and Chief of Norwegian Armed Forces Cyber DefenceThe protocol offers a plug-and-play cybersecurity mesh designed to protect any blockchain or enterprise system from the sub-zero layer upward, without requiring a hard fork. Its decentralized security layer is powered by post-quantum cryptography and AI, and aligned with standards from NIST, NATO, and ETSI.Naoris Protocol also runs a quantum-resistant Layer 1 blockchain secured by its proprietary Proof-of-Security (dPoSec) consensus mechanism.About Naoris ProtocolNaoris Protocol is the world’s first Decentralized Post-Quantum Infrastructure, built to secure both Web3 and Web2 against traditional and quantum threats. Operating beneath blockchain layers 0 to 3 as a Sub-Zero Layer, it integrates with existing EVM chains, nodes, bridges, dApps, enterprise systems, and IoT devices without requiring hard forks. Naoris Protocol combines Post-Quantum Cryptography, dPoSec Consensus, and Decentralized Swarm AI to create a self-healing security mesh that eliminates single points of failure. Since launching in January 2025, it has processed over 64 million transactions and mitigated 341 million threats. Powered by the $NAORIS token, it is the fastest-growing trust and security layer for a quantum-resilient internet.To learn more about Naoris Protocol, visit https://www.naorisprotocol.com/ Press contact:Anna Fedorovaanna@babslabs.io Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Synology參與COMPUTEX 2025 展示全新企業級儲存、備份及影像監控等解決方案 ACN Newswire

Synology參與COMPUTEX 2025 展示全新企業級儲存、備份及影像監控等解決方案

香港, 2025年5月29日 - (亞太商訊 via SeaPRwire.com) - 5 月 22 日,Synology 群暉科技於 COMPUTEX 2025 展示最新產品與服務,包括企業儲存、資料保護、影像監控、企業生產力與個人私有雲的完整解決方案。圖1:Synology 2025 Computex 展示區「Synology 的目標始終是建立一個值得客戶信賴的資料管理生態系。」 Synology 董事長暨執行長翁英暉表示, 「我們設計的解決方案不僅提供高度易用性,更具備領先業界的安全性、可靠性和資料私隱性,讓企業與個人都能安心掌握資料主權。」圖2:Synology 全新旗艦企業級儲存裝置 PAS 7700雙主動式 NVMe 全快閃儲存:PAS7700PAS7700 是 Synology 全新旗艦企業級儲存裝置,專為關鍵任務工作負載而打造,具備雙控制器主動式架構,確保服務持續不中斷。同時以安全為核心,內建 3-2-1-1 資料保護能力,並從各層面保障資料完整性。PAS7700 提供卓越效能與極致成本效益,採用端對端 NVMe 架構,提供高達 200 萬 IOPS 與低於毫秒的延遲,效能比現有 Synology 機種高出 3 倍。圖3:Synology 全新ActiveProtect 備份專用一體機 DP7200全新 ActiveProtect 備份專用一體機:DP7200繼推出 ActiveProtect DP7400 之後,Synology 宣布全新 DP7200 上市,進一步擴展資料保護產品線。DP7200 可作為分支據點的獨立備份伺服器,亦能於總部作為 CMS 控制中心,依企業需求靈活部署。DP7200 可集中管理組織內的多元工作負載,並內建不可變快照與網路隔離功能,有效防範資安威脅,確保企業隨時擁有可用的乾淨還原版本。圖4:Synology 全新雲端 VMS 系統 C2 SurveillanceSynology 全新雲端 VMS 系統:C2 Surveillance在既有的本地端影像監控生態系統之上,Synology 推出基於雲端的影像管理系統 C2 Surveillance,無需 NVR 伺服器即可部署,適用更多元的監控場景。C2 Surveillance 專為快速架設和輕鬆擴展而打造,透過雲端集中管理、整合 Windows AD 以及細緻權限分配,相當適合大規模、多站點部署。同時支援邊緣錄影與故障備援模式,確保不錯過任何一個關鍵時刻。圖5:Synology 生產力應用套件展示區生產力應用升級:ChatPlus 與 Synology Meet為滿足企業高效且安全的內部溝通,Synology Office Suite 將帶來新成員:Synology ChatPlus 與 Synology Meet。ChatPlus 提供安全的團隊溝通環境,支援細緻權限設定與頻道管理;Synology Meet 則是為企業打造的專業級視像會議解決方案。兩款套件皆運行於 Synology 的私有雲架構,企業得以完整掌控資料並確保高度隱私性。圖6:Synology Digital Life 系列新品- BeeStation Plus專為個人設計的私有雲:BeeStation PlusBeeStation Plus 是專為個人使用者設計的私有雲解決方案,可自動備份 iCloud 相簿,並整合 Plex Media Server,提供無縫串流體驗。透過 BeeProtect,則支援快照還原與異地備份功能,守護珍貴的資料與回憶。同時,搭配 Synology CC400W 攝影機,BeeStation Plus 亦提供智慧家庭監控功能。透過全新流動應用程式,可即時偵測人員出入、寵物活動、環境聲響與異常破壞行為,並即時發送通知,讓用戶隨時掌握家中狀況。圖7:Synology 香港代理商、當地合作夥伴與 Synology 高階業務管理團隊合影COMPUTEX 現場同步展出 Synology 最新 25 系列產品、雲端創新應用以及 AI 技術成果。本次展覽也獲得國際合作夥伴的熱烈支持,均有來自香港當地代理商與重要合作夥伴皆親臨現場共襄盛舉,展現對 Synology 長期合作關係的重視;此外,香港地區亦邀請多家知名 商業媒體與科技媒體出席,讓這場盛會增添更多國際關注與專業洞見。欲了解更多Synology群暉科技產品和解決方案詳情或有任何需求,歡迎至Synology群暉科技官網或聯繫 hk.event@synology.com圖片下載:https://bit.ly/3SdGUHp關於 Synology 群暉科技成立於 2000 年,Synology 專注於資料管理領域,提供資料儲存、備份、檔案協作、影像監控管理以及網路架構解決方案,目前在全球已累積超過 1000 萬名用戶,並在網路儲存設備 (NAS)專業使用者及企業市場取得領先地位。隨著資料成為各產業轉型核心,未來 Synology 將持續協助全球企業妥善管理、保護每一份資料,簡化 IT 管理流程。媒體聯繫窗口:Sandra Soh (Synology Regional Marketing)Email : sandrasoh@synology.com聯繫電話:+886 0905027104Andico Tsui (Senior Account Manager of SPRG)Email: andico.tsui@sprg.com.hk聯繫電話:+852 2114 4346 / 6902 3831 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully ACN Newswire

Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully

- ASGH brought together more than 2,900 participants from 42 countries and regions- Medical Fair attracted some 13,000 buyers from 57 countries and regions- The two flagship events together resulted in over 390 deal-making sessions and more than 660 business matching meetings- Collaboration agreements were signed during the events, covering areas including patient care, diagnostic solutions, innovative medical devices, and medical imagingHONG KONG, May 28, 2025 - (ACN Newswire via SeaPRwire.com) – The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. ASGH attracted over 2,900 participants from 42 countries and regions, while the Medical Fair received some 13,000 buyers from 57 countries and regions. Over 390 one-on-one deal-making sessions and more than 660 business matching meetings were arranged, facilitating over 1,000 high-quality collaborations and connections. The IHW continues to foster global exchange and cooperation, putting a spotlight on Hong Kong’s vast potential in healthcare investment and trade, and reinforcing its position as a regional leading medical hub.Dr Peter K N Lam, Chairman of the HKTDC, said: "The Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair concluded with outstanding results driving new collaborations and investments, and injecting new momentum into the healthcare industry. The events brought together leaders across government, business, academia, and investment to tackle today’s healthcare challenges, highlighting Hong Kong’s unique advantages as an international innovation and technology hub under its ‘eight centres’ positioning, actively advancing medical technology, connecting global innovation resources, and paving the way for a healthier and more inclusive future."Over 80 industry experts shared insights on healthcare developmentThe two-day ASGH, jointly organised by the HKSAR Government and the HKTDC under the theme ‘Fostering Global Collaboration for a Shared Future’, focused on a wide spectrum of topics including public health, medical technology breakthroughs, healthy ageing and global business and investment collaboration. The event featured more than 80 speakers comprising government officials and organisations, research pioneers, investors, and business leaders from around the world, all contributing valuable insights to advance global well-being.Prof Lo Chung-mau, Secretary for Health of the HKSAR Government, delivered a keynote speech during the Plenary Session I: Shaping a More Equitable and Sustainable Health System. Other distinguished speakers, including Dr Wu Xiaobin, Vice President of China Pharmaceutical Innovation and Research Development Association; Martin Taylor, Representative to China, World Health Organization; Prof Nancy Ip, President of the Hong Kong University of Science and Technology; and Frédéric Rimattei, Special Envoy for International Affairs of the President of French University Hospitals National Association, shared their insights on tackling global healthcare challenges, offering inspiration for the international healthcare community.In Plenary Session II: Fostering Global Collaboration for a Shared Future, speakers engaged in a lively discussion on trends in global healthcare collaboration. Among them was Ambassador George Hara, Group Chairman and CEO of DEFTA Partners and former Special Advisor to the Cabinet Office of the Prime Minister of Japan, who remarked that more advanced technology and new government regulations are needed to reach a compromise between companies' profits and patients' needs.During the Dialogue with Global Pioneer in Health session, Prof John Hardy, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, shared his latest research findings and advanced developments in Alzheimer's disease.The summit co-organised sessions under the overarching theme, Shaping the Future of Healthcare, with the Hong Kong University of Science and Technology for the first time. The discussion focused on the potential of AI in healthcare and how innovation could drive breakthroughs in the field. Dr Alex Ng, President of Tencent Healthcare, commented: “One uniqueness of tech companies is that they can be easily distracted by the latest thing. But you do need companies with patience and perseverance to stay in healthcare and make it work.” Prof Graham Cooke, Vice-Dean (Research) Medicine of Imperial College London, also noted that embedding patient needs into healthcare systems is critical, as many innovations fail in translation due to a lack of this focus, with universities playing a key role as innovation drivers.In Beyond ‘Healthy China 2030’: Driving Health Innovation, speakers explored opportunities in the mainland healthcare market. Marc Horn, Executive Vice President of Merck and President of Merck China, highlighted the two-phase approach of "China for China" followed by "China for the globe”, emphasising healthcare collaboration to develop advanced treatments for global benefit. Dr Zhang Lianshan, Executive Vice President of Jiangsu Hengrui Pharmaceuticals Co., Ltd., stated: "We would like to see our health innovation have realisation of its value, not only in China, but also outside of China. That is why we are talking about Globalisation, where we can achieve maximum value."With growing global attention on healthy ageing, the summit introduced a dedicated Silver Health Chapter. A highlight was the thematic session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, where Prof Jean Woo, Director of Chinese University of Hong Kong Jockey Club Institute of Ageing, Prof James L. Kirkland, Director of Cedars-Sinai’s Centre for Advanced Gerotherapeutics, and fellow experts explored both the challenges and opportunities posed by ageing populations. Prof Jean Woo highlighted that rapid population ageing is reshaping the global healthcare and socioeconomic landscape. As a city with one of the world’s longest life expectancies, Hong Kong must take early action to strengthen elderly care policies and better allocate health resources. Prof James L. Kirkland also noted that geriatricians ultimately aim to help patients with multiple illnesses reduce medication use while treating their conditions more effectively, enhancing their overall quality of life.Over 390 deal-making sessions and cooperation agreements open new global opportunitiesA key feature of the summit was the ASGH Deal-Making session, which facilitated one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations. Investment projects spanned pharmaceuticals, medical devices and diagnostics, smart healthcare, and community health and wellness and more than 390 one-on-one meetings were successfully arranged for angel investors, venture capitalists, corporate venture arms, private equity firms and family offices.The summit facilitated the signing of cooperation agreements, such as those between Gleneagles Hospital Hong Kong and Emerging Viral Diagnostics, and a tripartite collaboration with PanopticAI and SmartCare, HKSH Medical Group and United Imaging Healthcare, China Resources Guangdong Pharmaceuticals and Hong Kong Medtech Association, Hugobiotech and Bridgeway Healthcare Technology, Canossa Hospital and KA Imaging, and others. These agreements covered diverse healthcare areas, including patient care, diagnostic solutions, innovative medical devices, medical imaging and more. Under the tripartite collaboration agreement between Gleneagles Hospital Hong Kong, PanopticAI, and SmartCare, the integration of PanopticAI’s camera-based vital signs monitoring technology and SmartCare’s patient-centered consultation platform will be implemented into Gleneagles clinic in the future.In addition to its discussion sessions, the summit also featured the ASGH Business Hub, showcasing more than 170 innovative technology companies related to the healthcare industry from 13 countries and regions, including the mainland (Shanghai and Xiamen), Australia, and Thailand, presenting projects and solutions across key areas such as medical innovation, smart healthcare, AI, big data, telemedicine, and cybersecurity. Zhong Wei, Co-founder of Mitrassist Lifesciences, joined the Shanghai Pavilion and said that ASGH helped them bring non-invasive medical monitoring technologies to Southeast Asia, Africa, and other Belt and Road Initiative countries.Medical Fair Drives Industry Innovation and Fosters Business CollaborationThe Medical Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, was held alongside ASGH. The Association—formerly known as the Hong Kong Medical and Healthcare Device Industries Association—held a renaming ceremony during the fair, showcasing the deep integration of medical technology and the industry.The fair brought together some 300 exhibitors from 13 countries and regions, featuring first-time pavilions from the United Kingdom, Thailand and Israel, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg. In addition, seven local universities, over 30 innovative technology companies at the Hong Kong Science and Technology Parks pavilion, and more than 20 medical enterprises brought by the Hong Kong MedTech Association participated. The Hong Kong Council of Social Service also participated in the fair for the first time. Under the theme Innovations Boosting Smart Health Experience, the exhibition spotlighted three major areas: MedTech, GeronTech and green solutions, with many exhibits featuring applications of AI.Many exhibitors and buyers successfully expanded their networks and forged new partnerships at the exhibition. Among them was Hong Kong exhibitor Eieling Technology, a company founded to commercialise research outcomes from the Hong Kong Polytechnic University. The firm showcased its non-invasive liver examination technology, which utilises transient elastography technology. Co-founder and CEO Xiaojia Jia noted that only about four companies worldwide possess this technology, making it a major draw for buyers. "During the exhibition, we received intention orders worth several million Hong Kong dollars from mainland China, Hong Kong, Indonesia, and Thailand, involving around ten devices. This is our third year participating, and we've observed a significant rise in buyers' professionalism during our discussions. We look forward to exhibiting again next year."Karel Lee, CEO of Neoneco from Korea, sourced innovative medical products at the fair with a minimum budget of USD100,000 and he has already identified RhinoCare, an exhibitor from the Israeli pavilion, for its nasal decongestion device, and is also interested in a medical examination device from a Hong Kong exhibitor. Lee stated, "The exhibition allows us to meet with exhibitors face-to-face, build trust, and accelerate the decision-making process. The HKTDC’s Click2Match platform also facilitated efficient business matching. I have already connected with ten exhibitors, and another twenty reached out to me after learning about my sourcing needs. This is one of Asia's premium medical sourcing events, and we will definitely return next year."Beyond business deals, insightful forums were arranged during the Medical Fair to give inspiration to industry buyers. These included The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area, The MedTech Nexus of the Greater Bay Area, co-organised with the Hong Kong MedTech Association, and Fostering Silver Economy, Leading Quality Elderly & Rehabilitation Care Practices, co-organised with the HKCSS. These forums attracted a strong attendance and offered valuable insights into healthcare. Selected sessions are available for replay on the Fair’s website for extended engagement.This year’s Fair continued to adopt the EXHIBITION+ hybrid model. Global exhibitors, industry professionals, and buyers could make use of the Click2Match and explore sourcing opportunities via HKTDC Sourcing (hktdc.com Sourcing). Click2Match will remain available until 4 June.WebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enAsia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/enHong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/enPhoto download: https://bit.ly/4kbr9NcThe fifth Asia Summit on Global Health was attended by over 2,900 participants from 42 countries and regionsProf Lo Chung-mau, Secretary for Health of the HKSAR Government, delivered a keynote speech on the first day during the Plenary Session I: Shaping a More Equitable and Sustainable Health SystemProf John Hardy, Chair of Molecular Biology of Neurological Disease at UCL Queen Square Institute of Neurology. As an internationally renowned neurogeneticist, Prof John Hardy has been awarded the Brain Prize for "groundbreaking research on the basis of Alzheimer's disease" and is known as the “father of Alzheimer’s disease genetic studies”. He shared his latest research findings and advanced developments during the Dialogue with Global Pioneer in Health sessionWith growing global attention on healthy ageing, the summit introduced a dedicated Silver Health Chapter for the first time. A highlight was the thematic session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, where Prof Jean Woo, Director of Chinese University of Hong Kong Jockey Club Institute of Ageing (far left), and fellow experts explore the challenges and opportunities posed by ageing populationsIn addition to its discussion sessions, the summit also featured the ASGH Business Hub, showcasing more than 170 innovative solutions from the healthcare industry across 13 countries and regionsASGH Deal-making facilitated over 390 one-on-one meetings(Front row from the left) Dr Kyle Wong, Chief Executive Officer and Co-founder of PanopticAI Limited, Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong, and Dr Justin Cheng, Chief Executive Officer and Co-founder of SmartCare Technology Co Limited signed a tripartite cooperation agreement witnessed by (back row from the left) Prof Nancy Ip, President of The Hong Kong University of Science and Technology, Dr Prem Kumar Nair, Group Chief Executive Officer of IHH Healthcare and Patrick Lau, Deputy Executive Director of Hong Kong Trade Development CouncilThe 16th Hong Kong International Medical and Healthcare Fair attracted some 13,000 buyers from 57 countries and regions who visited the fair for sourcing and procurementThe Hong Kong MedTech Association had a delegation of over 20 companies participating in the fair, attracting strong interest from buyers who engaged with exhibitors to explore business opportunitiesThe United Kingdom pavilion, participating in the Medical Fair for the first time, promoted innovative medical devices, solutions and services from multiple companies at the fairAn expert from the Greater Bay Area Center for Medical Device Evaluation and Inspection of the National Medical Products Administration; Eva Wong, Senior Electronics Engineer, Medical Device Division of Department of Health (pictured); along with SGS-CSTC Standards Technical Services Co., Ltd.’s expert, shared insights at The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area forumCo-organised by the Hong Kong Council of Social Service, the Fostering Silver Economy, Leading Quality Elderly & Rehabilitation Care Practices forum drew a strong turnout from industry professionalsMedia enquiriesFor enquiries, please contact Yuan Tung Financial Relations Limited:Louise SongTel: (852) 3428 5691Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Asia Summit on Global HealthSharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgHong Kong International Medical and Healthcare FairKelly ShekTel: (852) 2584 4537Email: kelly.yt.shek@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Modern Dental Group’s Thai Subsidiary Hexa Ceram Held 30th Anniversary Celebration and Dental Symposium ACN Newswire

Modern Dental Group’s Thai Subsidiary Hexa Ceram Held 30th Anniversary Celebration and Dental Symposium

HONG KONG, May 28, 2025 - (ACN Newswire via SeaPRwire.com) – Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600.HK), a leading global dental prosthetic devices provider, announced the successful launch of the 30th Anniversary Celebration and Symposium “Hexallence Beyond 30: Pioneering Tomorrow’s Dentistry” by its Thai subsidiary Hexa Ceram Dental Laboratory (“Hexa Ceram”) in Bangkok, Thailand on 24th May. As a crucial segment of Modern Dental Group's strategic framework in the Asia-Pacific region, Hexa Ceram's 30th anniversary celebration is not only a milestone for the industry but also marks a new starting point for the collaborative development of both parties.In the 30 years since its establishment in 1995, Hexa Ceram has been committed to promoting innovation in dental technology. By 2023, its local market share reached 29%, making it the top dental laboratory in Thailand. It has become a benchmark company in the dental field in Thailand and Southeast Asia. Themed "Pioneering Tomorrow’s Dentistry", this year's celebration aims to review the technological advancements and industry contributions of the brand over the past 30 years, and to open up a forward-looking vision in dentistry for practitioners through insightful discussions with top-tier scholars globally. The symposium specially invited 300 dentists, 100 VIP customers in the industry, dean from 10 top universities and presidents of dental associations to jointly build a blueprint for the future development of dentistry. At this new milestone, Hexa Ceram is dedicated to delivering high-quality and innovative dental solutions and services continuously. It is committed to expanding the presence in the ASEAN Economic Community, fostering growth and excellence in dental care.The global dental industry is currently undergoing an accelerated transformation from traditional models to precision-driven and intelligent approaches. With Hexa Ceram officially incorporated into the global system of Modern Dental Group, the two parties will continue to strengthen their leadership in the Thai market through technological innovation, resource synergy and integration, and effectively promote the Group's competitiveness in the global dental industry value chain. Looking ahead, the Group will continue to maintain its focus on digital innovation as a catalyst and give full play to the strategic role of Hexa Ceram to build a dental ecosystem network in Southeast Asia. Through international technology integration, service model advancements and global resource collaboration, we strive to elevate oral diagnosis and treatment technology in Southeast Asia and globally, delivering transformative dental solutions.About Modern Dental Group Modern Dental Group Limited (Stock code: 03600.HK) is a leading global dental prosthetics provider, distributor and consultant with a focus on providing custom-made prostheses to customers in the growing prosthetics industry. Our product portfolio is broadly categorized into three product lines: fixed prosthetic devices, such as crowns and bridges; removable prosthetic devices, such as removable dentures; and other devices, such as orthodontic devices, sports guards, clear aligners, and anti-snoring devices.Modern Dental Group has a global portfolio of respected brands, including Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA and MicroDental in the United States, Modern Dental Pacific in Australia and New Zealand, Modern Dental SG in Singapore, Modern Dental TW in Taiwan, and Apex Digital Dental in Malaysia. We have grown these brands by providing premium and consistent quality products and superior customer service. We have more than 80 service centers in over 28 countries and serve over 30,000 customers. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
現代牙科集團泰國公司Hexa Ceram舉辦三十周年慶典暨牙科論壇 ACN Newswire

現代牙科集團泰國公司Hexa Ceram舉辦三十周年慶典暨牙科論壇

香港, 2025年5月28日 - (亞太商訊 via SeaPRwire.com) - 全球領先之義齒器材供應商 - 現代牙科集團有限公司 (簡稱「現代牙科」或「本集團」,股份代號:03600.HK) 旗下泰國牙科實驗室Hexa Ceram Dental Laboratory ("Hexa Ceram") 於5月24日在泰國曼谷舉辦「Hexallence Beyond 30: Pioneering Tomorrow's Dentistry」30 周年慶典暨學術交流論壇。作為現代牙科集團在亞太區域戰略版圖的重要落子,Hexa Ceram三十周年慶典不僅是行業共襄盛舉的里程碑,更標誌著雙方協同發展的全新起點。自 1995 年成立至今三十年,Hexa Ceram秉持推動齒科技術革新使命,至2023年當地市佔率達29%,為泰國TOP1牙科實驗室,已成為泰國及東南亞齒科領域標桿企業。本屆慶典以「開拓牙科未來」為主題,旨在回顧品牌三十年技術沉澱與行業貢獻,通過全球頂尖學者的巔峰對話,為從業者開啟齒科領域的前瞻視野。盛典特邀全球300位牙醫、100位業界菁英客戶、10所頂尖學府院長及牙科協會主席,共繪齒科發展藍圖。在迎接新的里程碑之際,Hexa Ceram將致力於提供高品質、創新的牙科解決方案和服務,持續擴大在東協經濟共同體中的影響力,促進對牙科產業發展的卓越追求與行業進步。當前全球齒科行業正經歷從傳統診療模式向精準化、智能化的加速轉型。隨著Hexa Ceram正式納入現代牙科集團全球體系,雙方將通過技術創新驅動與資源協同整合,持續強化在泰國市場的領導地位,並有力推動集團在全球齒科產業價值鏈中的競爭力。展望未來,集團將持續以數碼化創新為引擎,充分發揮Hexa Ceram的戰略作用構建輻射東南亞的齒科生態網路。通過技術跨界融合、服務模式革新與全球資源聯動,集團致力推進東南亞地區以至全球口腔診療技術提升,締造突破性的齒科解決方案。關於現代牙科集團現代牙科集團有限公司 (股份代號: 03600.HK) 為全球領先的義齒器材供應商、經銷商和顧問,專注於發展迅速的義齒行業為客戶提供定制式義齒。我們的產品組合大致可分為三類﹕固定義齒器材,例如牙冠及牙橋;活動義齒器材,例如活動義齒;及其他器材,例如正畸類器材、透明牙套、運動防護器及防鼾器。現代牙科集團擁有多個備受稱許的全球品牌,包括西歐的Labocast、Permadental及Elysee Dental、中國的洋紫荊牙科器材、香港的現代牙科器材、美國的Modern Dental USA及MicroDental 、澳洲及紐西蘭的Modern Dental Pacific、新加坡的Modern Dental SG、台灣的 Modern Dental TW及馬來西亞的 Apex Digital Dental等。我們提供穩定和優質的產品及卓越的客戶服務,令這些公司品牌能茁壯成長。我們於全球超過 28個國家擁有超過 80 家服務中心及服務逾 30,000 名客戶。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
Euro Manganese Closes C$11.2 million (A$12.3 million) Financing ACN Newswire

Euro Manganese Closes C$11.2 million (A$12.3 million) Financing

Highlights Financing included an upsized C$9.8 million (A$10.8 million) Private Placement and an oversubscribed A$1.5 million (C$1.4 million) Share Purchase PlanCompany welcomes the European Bank of Reconstruction and Development and Eric Sprott as significant shareholdersFunds raised to support ongoing development of the Chvaletice Manganese Project and customer engagements to secure additional offtake term sheets and strategic investmentsVancouver, British Columbia--(ACN Newswire via SeaPRwire.com - May 28, 2025) - Euro Manganese Inc. (TSXV) (ASX: EMN) (FSE: E060) (the "Company" or "Euro Manganese") is pleased to announce that, following the approval by its shareholders at its Annual General and Special Meeting held on May 15, 2025 (the "AGSM"), it has closed the previously announced financing package which included: (a) a private placement (the "Placement") of common shares ("New Shares") and CHESS Depositary Interests ("New CDIs" together with the New Shares, "New Securities") in the capital of the Company of C$9.8 million (approximately A$10.8 million); and (b) a Share Purchase Plan ("SPP", together with the Placement, the "Financing") with certain eligible shareholders in the amount of A$1.5 million (approximately C$1.4 million). The Company also announces an option grant to certain directors, officers, employees, and consultants as described below.Martina Blahova, CEO of Euro Manganese, commented:"We are extremely pleased with the strong support demonstrated by both our existing shareholders and new investors, including the notable participation of Mr. Eric Sprott. As Euro Manganese's largest shareholder, EBRD's investment reinforces its support and commitment to the Chvaletice Project. This critical financing enables the Company to pursue certain key milestones and advance project development. We thank shareholders for their ongoing support."The net proceeds of the Financing will be used to support ongoing development of the Chvaletice Manganese Project, including customer engagements to secure additional offtake term sheets and strategic investments, the operation of the demonstration plant, as needed, to market the Company's product to potential customers and to advance permitting.All defined terms in this press release have the same meaning as set out in the press releases dated March 6, 2025 and April 1, 2025, unless such terms are otherwise defined herein.Details of the PlacementThe Placement consisted of the issuance of an aggregate of 54,578,350 New Securities, comprised of 39,671,662 New Shares at a price of C$0.18 per New Share and 14,906,688 New CDIs (with each New CDI representing one New Share) at a price of A$0.195 per New CDI, and 54,578,350 Warrants for aggregate gross proceeds of C$9.8 million (approximately A$10.8 million). Warrants issued in connection with the Placement are exercisable any time prior to November 28, 2026 (Vancouver), and have an exercise price of C$0.225 per New Security. Included in the Placement were:14,650,278 New CDIs and 14,650,278 Warrants subscribed for under the Placement led by the Joint Lead Managers (as defined below);39,463,331 New Shares and 39,463,331 Warrants subscribed for directly with the Company, which included (i) 21,400,000 New Shares and 21,400,000 Warrants subscribed for by the European Bank for Reconstruction and Development ("EBRD") (the "EBRD Subscription"); (ii) 16,666,666 New Shares and 16,666,666 Warrants subscribed for by Mr. Eric Sprott, through 2176423 Ontario Ltd., a corporation which is beneficially owned by Mr. Sprott; and (iii) 1,396,665 New Shares and 1,396,666 Warrants subscribed for by other, non-related investors; andsubscriptions by directors of the Company for 464,741 New Securities (comprised of 208,331 New Shares and 256,410 New CDIs) and 464,741 Warrants (the "Related Party Subscription").As the number of New Securities and Warrants issued under the Placement led by the Joint Lead Managers, pursuant to the EBRD Subscription, and subscribed for directly with the Company exceeded the number of securities permitted to be issued without obtaining prior shareholder approval under Listing Rule 7.1 of the Australian Securities Exchange ("ASX"), the Company was required to seek shareholder approval. Similarly, the Related Party Subscriptions were subject to shareholder approval as required by ASX Listing Rule 10.11.1 and 10.11.4. Resolutions approving these issues were sought and received at the AGSM.Since certain directors and management of the Company participated in the Placement, the Placement is considered to be a related party transaction subject to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101 on the basis that participation in the Placement by such directors and management does not exceed 25% of the fair market value of the Company's market capitalization, as calculated in accordance with MI 61-101.Details of the Share Purchase PlanThe SPP was conducted pursuant to a Prospectus dated April 23, 2025 and was comprised of 7,692,307 New CDIs at a price of A$0.195 per CDI, and 7,692,307 Warrants, for aggregate gross proceeds of A$1.5 million (approximately C$1.4 million). Warrants issued in connection with the SPP are exercisable any time prior to November 28, 2026 (Vancouver), with an exercise price of C$0.225 per New Security.As announced in the Company's news release of May 15, 2025, the SPP was oversubscribed and subscriptions were scaled back to the maximum aggregate amount permitted.As the number of New CDIs and Warrants issued under the SPP exceeded the Company's Placement Capacity under ASX Listing Rule 7.1, the Company was required to seek shareholder approval, such approval having been received at the AGSM.Broker Fees and Additional WarrantsCanaccord Genuity (Australia) Limited ("Canaccord Genuity") and Foster Stockbroking Pty Ltd ("FSB", together with Canaccord Genuity, the "Joint Lead Managers") acted as Joint Lead Managers and Bookrunners for the Financing. Aggregate fees payable in cash by the Company to Canaccord Genuity and FSB in connection with the Financing consisted of A$498,918 (approximately C$454,016).In addition, the Company also issued 4,904,478 broker warrants (the "Broker Warrants") to Canaccord Genuity and FSB, representing 12% of the aggregate number of New Securities issued under the Placement and the SPP, excluding those issued pursuant to the EBRD Subscription. The Broker Warrants are exercisable any time prior to May 28, 2027 (Vancouver), with an exercise price of C$0.225 per New Security.Additionally, as announced previously on March 6, 2025 and April 1, 2025, and in connection with an amendment to the Company's Convertible Loan Royalty Agreement (the "CLRA") with OMRF (BK) LLC ("Orion") the Company has issued 22,263,733 warrants to purchase New Securities (the "Additional Warrants") to Orion, exercisable any time prior to November 28, 2026 (Vancouver), with an exercise price of C$0.225 per New Security. Additional details about the CLRA are available in the news releases of the Company dated December 3, 2024, November 29, 2023 and November 27, 2023.As the number of the Broker Warrants and Additional Warrants exceeded the Company's Placement Capacity under ASX Listing Rule 7.1, the Company was required to seek shareholder approval, such approvals having been received at the AGSM.Applicable Hold PeriodsNew Shares issued or made issuable under the Financing will not be permitted to be traded in or into Canada or through the facilities of the TSX Venture Exchange (the "TSX-V") prior to a four month and one day statutory hold period expiring on September 29, 2025 (Vancouver), and will be subject to legending requirements under Canadian securities laws. New Shares will be listed on the TSX-V and New CDIs listed on the ASX. The Warrants, Broker Warrants and Additional Warrants will not be listed. New CDIs will not be permitted to be exchanged for common shares and traded through the facilities of the TSX-V prior to the four month and one day statutory hold period expiring on September 29, 2025 (Vancouver).The Warrants, Broker Warrants and Additional Warrants will not be listed. Common shares issued upon exercise of the Warrants, Broker Warrants or Additional Warrants prior to September 29, 2025 (Vancouver) are subject to the same restrictions noted above.The Warrants, Broker Warrants or Additional Warrants may not be traded in or into Canada prior to September 29, 2025 (Vancouver) and will be subject to legending requirements under Canadian securities laws.Early Warning Disclosure for The European Bank for Reconstruction and DevelopmentEBRD acquired the 21,400,000 units pursuant to the Placement at a price per unit of C$0.18 for total consideration of C$3,852,000.Prior to the completion of the EBRD Subscription, EBRD owned 3,560,000 common shares, representing an ownership interest of 4.42% of the issued and outstanding common shares of the Company. On completion of the EBRD Subscription, EBRD's ownership interest increased to 24,960,000 common shares, representing an ownership interest of 17.48% of the issued and outstanding common shares and an increase of 13.06%. Assuming the exercise by EBRD of all its Warrants, and assuming the exercise of (i) all Warrants issued under the Placement, (ii) all Warrants issued under the SPP, and (iii) all Additional Warrants, EBRD's ownership interest will be in aggregate 46,360,000 common shares, representing an aggregate beneficial ownership interest of 19.96% of the issued and outstanding shares and an increase of 15.54%. EBRD has agreed, pursuant to the terms of the Warrants issued to EBRD, that for so long as the Company is listed on the TSX-V, unless approval from the TSX-V and disinterested shareholders of the Company have been obtained pursuant to the policies of the TSX-V (provided that such approval is required at the relevant time), EBRD will not be permitted to exercise such number of warrants that would result in it beneficially owning more than 19.99% of the outstanding common shares of the Company.EBRD acquired the New Shares and Warrants for investment purposes. Depending on market conditions and other factors, EBRD may from time to time acquire and/or dispose of securities of the Company or continue to hold its current position.To obtain a copy of the early warning report to be filed by EBRD in connection with this press release, please contact: Michael Zlobin at +44 207338 8981. EBRD's address is 5 Bank Street, London, E14 4BG, United Kingdom.Early Warning Disclosure for Eric SprottEric Sprott, through 2176423 Ontario Ltd., a corporation that is beneficially owned by him acquired 16,666,666 units pursuant to the Placement, at $0.18 per unit for total consideration of C$3,000,000. Prior to the Placement, Mr. Sprott did not beneficially own or control any securities of the Company. As a result of the Placement, Mr. Sprott now beneficially owns 16,666,666 Shares and 16,666,666 Warrants, representing approximately 11.7% of the outstanding Shares on a non-diluted basis and 20.9% of the outstanding Shares on a partially-diluted basis assuming exercise of such Warrants.The securities are held for investment purposes. Mr. Sprott has a long-term view of the investment and may acquire additional securities including on the open market or through private acquisitions or sell the securities including on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.A copy of the early warning report with respect to the foregoing will appear on Euro Manganese's profile on SEDAR+ at www.sedarplus.ca and may also be obtained by calling Mr. Sprott's office at (416) 945-3294 (2176423 Ontario Ltd., 7 King Street East, Suite 1106, Toronto Ontario M5C 3C5).Option GrantThe Company today also granted stock options ("Options") to certain of its directors, officers, employees, and consultants to purchase up to an aggregate of 7,020,000 common shares ("Shares"). Of these, 1,330,000 Options have been granted to directors, 2,530,000 Options have been granted to officers, and 3,160,000 Options have been granted to employees and consultants. The Options are exercisable for a term of ten years at an exercise price of CAD$0.19 per Share. All of the Options will vest one-third immediately and then one third on each of the first and second anniversaries of today's date of grant, except that 1,650,000 of the Options granted to certain officers, employees and consultants will all vest immediately in recognition of such individuals work in managing the successful completion of the oversubscribed Financing.Interim CFOAs announced earlier this month, the Company will be appointing a new Chief Financial Officer ("CFO") in the coming weeks. Until such time, following the departure of Dean Larocque as CFO on May 30, 2025, Martina Blahova will serve as interim CFO.About Euro Manganese Euro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry. The Company is advancing development of the Chvaletice Manganese Project in the Czech Republic and an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec.The Chvaletice Project is a unique waste-to-value recycling and remediation opportunity involving reprocessing old tailings from a decommissioned mine. It is also the only sizable resource of manganese in the European Union, strategically positioning the Company to provide battery supply chains with critical raw materials to support the global shift to a circular, low-carbon economy.Euro Manganese is dual listed on the TSX-V and the ASX.Authorized for release by the CEO of Euro Manganese Inc.Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) or the ASX accepts responsibility for the adequacy or accuracy of this release. Enquiries Martina BlahovaChief Executive Officer+1 (604) 681-1010martina@mn25.caLodeRock AdvisorsNeil WeberInvestor and Media Relations - North America+1 (647) 222-0574 neil.weber@loderockadvisors.comJane Morgan Management Jane Morgan Investor and Media Relations - Australia +61 (0) 405 555 618 jm@janemorganmanagement.com.auCompany Address: #709 -700 West Pender St., Vancouver, British Columbia, Canada, V6C 1G8Website: www.mn25.caFollow us on: LinkedIn | Twitter | YouTubeClick Here to Subscribe to our mailing list for updatesForward-Looking StatementsCertain statements in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, its Chvaletice Project, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", "scheduled", "forecast", "predict" and other similar terminology, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company.All forward-looking statements are made based on the Company's current beliefs including various assumptions made by the Company including that the Chvaletice Project will be developed and operate in accordance with current plans, appointment of permanent CFO, that the Company will be able to raise the financing that it requires, and that it will meet conditions of its secured credit facility. Factors that could cause actual results or events to differ materially from current expectations include, among other things: risks and uncertainties related to the Company's ability to meet the conditions of its secured credit facility, risks related to maintaining and securing necessary licenses or permits; risks related to acquisition of surface rights; inability to secure sufficient offtake agreements; the availability of acceptable financing; the potential for unknown or unexpected events to cause contractual conditions to not be satisfied; developments in EV (Electric Vehicles) battery markets and chemistries; and risks related to fluctuations in currency exchange rates, changes in laws or regulations; and regulation by various governmental agencies. For a further discussion of risks relevant to the Company, see "Risk Factors" in the Company's annual information form for the year ended September 30, 2024, available on the Company's SEDAR+ profile at www.sedarplus.ca.Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release.NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/253771 Copyright 2025 ACN Newswire via SeaPRwire.com.
More
SAPPE Makes a Global Splash in the Beverage Market, Unveils Global Campaign “Life’s too Short, You Gotta Chew” at THAIFEX – ANUGA ASIA 2025 ACN Newswire

SAPPE Makes a Global Splash in the Beverage Market, Unveils Global Campaign “Life’s too Short, You Gotta Chew” at THAIFEX – ANUGA ASIA 2025

BANGKOK, May 28, 2025 - (ACN Newswire via SeaPRwire.com) - Sappe PCL (SAPPE), a pioneer in beverage innovation from Thailand that has gained recognition among consumers worldwide, is set to reinforce its global brand ambition at THAIFEX – ANUGA ASIA 2025, Asia’s premier food and beverage trade exhibition. The event will take place from May 27–31, 2025, at Booth 1-QQ01, Impact Challenger Hall 1, Muang Thong Thani, Bangkok, Thailand.The highlight of this year’s showcase is the official launch of Mogu Mogu’s new global campaign, “Life’s too Short, You Gotta Chew” presenting the world’s first Snackable Drink, a category created by SAPPE itself. The campaign marks a major milestone in reshaping the global beverage experience by blending taste, texture, and lifestyle in one fun and refreshing product.Mission to Mars: A Thai Brand Journey to the Future of Global GrowthUnder the concept of “Mission to Mars,” SAPPE’s exhibition booth is designed to resemble a spacecraft transporting over 10 beverage brands from Thailand on a journey into the future. The concept symbolizes bold creativity, forward thinking, and the ambition to share Thai-made innovations with consumers worldwide.Featured products include Mogu Mogu, Sappe Aloe Vera, Sappe Beauti, and the company’s newest innovations designed with a strong focus on quality, taste, functionality, health benefits, and environmental responsibility, to meet the evolving preferences of today’s global consumers.Mogu Mogu: Turning Ordinary Days into Chewable FunThe “Life’s too Short, You Gotta Chew” campaign makes its global debut at the event, supported by three vibrant new TV commercials. The campaign highlights Mogu Mogu’s playful, upbeat personality and connects with today’s young consumers who seek Social Connection, FOMO (Fear of Missing Out), Instant Gratification, and a lifestyle filled with fun and spontaneity.SAPPE is working with key partners in major international markets including South Korea, Philippines, France, and the United Kingdom to expand the campaign’s global reach and deepen engagement with Mogu Mogu’s growing fan base. The company aims to significantly increase international brand engagement by the end of this year.Beyond Export: SAPPE’s Vision to Build a Lasting Global BrandMs. Piyajit Rackariyapong, Chief Executive Officer of SAPPE, said:“We don’t just export beverages. Our mission is to build a brand from Thailand that leads with innovation, offers new excitement and drinking experiences to consumers, and brings positivity into people’s everyday lives.”SAPPE’s consistent participation in THAIFEX – ANUGA ASIA for over a decade reflects the company’s commitment to becoming a creative force in the global beverage industry driven by bold ideas, cultural connection, and consumer empathy.THAIFEX – ANUGA ASIA: A Global Value Chain GatewayOrganized by Thailand’s Department of International Trade Promotion (DITP) in partnership with the Thai Chamber of Commerce and Koelnmesse Germany, THAIFEX – ANUGA ASIA serves as a critical platform for Asian food and beverage brands to connect with the global value chain. SAPPE continues to be one of the most prominent Thai brands recognized annually on this stage.Visit SAPPE at Booth 1-QQ01, IMPACT Challenger Hall 1, Muang Thong Thani, Bangkok, Thailand, throughout the 5-day event. Follow Mogu Mogu’s global journey at www.mogumogu.comAbout SAPPESappe Public Company Limited (SAPPE) is a leading Thai beverage innovator and the owner of several iconic brands. The company specializes in fruit juice and functional drinks, developed to serve the modern lifestyle of consumers across global markets. SAPPE currently exports to over 100 countries worldwide, with a strong presence in Asia, Europe, and the Middle East.Its portfolio includes globally recognized brands such as Mogu Mogu, the world’s first Snackable Drink; Sappe Aloe Vera, known for its refreshing taste and natural ingredients; and Sappe Beauti, a health-focused functional drink line. SAPPE is headquartered in Bangkok, Thailand, and is listed on the Stock Exchange of Thailand (SET) under the symbol SAPPE.Driven by innovation, consumer insights, and sustainability, SAPPE is committed to delivering high-quality products that bring joy, well-being, and new experiences to people around the world.Sappe official: https://www.sappe.com/en/Facebook: https://www.facebook.com/sappeplaygroundInstagram: https://www.instagram.com/mogumogu_global/Line: https://shop.line.me/@sappeonlineShopee: https://shopee.co.th/sappe.officialEmail: corpcom@sappe.com Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Top Business and Policy Leaders to Convene at CGS International’s ASEAN Business Forum 2025 to Scale Intra-ASEAN and International Trade and Investment ACN Newswire

Top Business and Policy Leaders to Convene at CGS International’s ASEAN Business Forum 2025 to Scale Intra-ASEAN and International Trade and Investment

KUALA LUMPUR, May 27, 2025 - (ACN Newswire via SeaPRwire.com) - CGS International Securities Pte Ltd (“CGS International”) and CGS International Securities Malaysia Sdn Bhd (“CGS MY”) in collaboration with MBSB and OCBC Malaysia, today at their curtain raiser for the inaugural ASEAN Business Forum 2025 (“ABF2025” or the “Forum”), shared key action points slated for intense discussion at the event to be held on 29 May 2025. ABF2025 will be held in conjunction with the 46th ASEAN Summit 2025 in Kuala Lumpur, and the ASEAN-GCC + China Summit 2025. A key highlight of the forum is the corporate engagement and business exchange session designed to drive real business collaboration between pre-screened and pre-selected matching parties from the top 25 corporations and investors across ASEAN and China.From left to right: En. Khairi Shahrin Arief Baki, Deputy CEO of CGS MY, Mr. Sivasuriyamoorthy Sundara Raja, Deputy CEO of MIDA (Investment Promotion and Facilitation), Puan Azizah Mohd Yatim, CEO of CGS MY, YBhg. Tan Sri NazirRazak, Chairman of the ASEAN-BAC for Malaysia, Ms. Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia, YBhg. Dato' Azlan Shahrim, Group Chief Strategy Officer of MBSB Berhad, and Mr. Alan Inn Wei Loon, Deputy CEO of CGS MY at the Curtain Raiser for the ASEAN Business Forum 2025.Themed “From Vision to Reality – ASEAN Partnerships Fuelling Sustainable Growth”, the forum is co-hosted with the Malaysian Investment Development Authority (MIDA) and ASEAN Business Advisory Council (ASEAN-BAC) Malaysia. It is expected to draw more than 600 attendees comprising over 200 foreign and local corporates, policymakers and corporate captains. They represent the region’s largest companies of over RM1 trillion in market capitalisation, council members of ASEAN BAC countries, and fund managers with total funds under management of over RM 8 trillion. The gathering comes at a critical juncture of a changing world order arising from United States tariffs, as affected countries explore alternative strategies to sustain economic stability and growth.Present at the curtain raiser were CGS International’s strategic partners, represented by YBhg. Tan Sri Nazir Razak, Chairman of the ASEAN-BAC for Malaysia, Mr. Sivasuriyamoorthy Sundara Raja, MIDA Deputy Chief Executive Officer (Investment Promotion and Facilitation), YBhg. Dato’ Azlan Shahrim, Group Chief Strategy Officer representing MBSB Berhad and Ms. Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia – both trusted banking partners committed to growing ASEAN financial ecosystems and supporting sustainable investment flows.Mr. Sivasuriyamoorthy Sundara Raja, MIDA Deputy CEO (Investment Promotion and Facilitation) shared, “We commend CGS International Securities for hosting the ASEAN Business Forum 2025 — a timely effort that speaks to the region’s shared aspiration for sustainable and inclusive prosperity, amidst geopolitical and challenging global economic landscape. At MIDA, we are committed to partnerships that go beyond transactions, that shape long-term value for Malaysia and uplift business communities. This forum bodes well with the statement of intent by ASEAN — to lead with shared purpose, unity, and economic vision. As the Malaysian government’s principal promotion agency, MIDA stands ready to facilitate investments that strengthen regional supply chain integration and elevate ASEAN on the global stage.”YBhg. Tan Sri Nazir Razak, Chairman of the ASEAN-BAC for Malaysia added, “Now, more than ever, ASEAN needs to strengthen bilateral ties and stay united. We need to be deliberate and realistic, taking concerted efforts to optimise intra-ASEAN trade and investments. Amongst our 12 priorities, initiatives such as the ASEAN Business Entity (ABE) directly facilitate this by enabling operational flexibility to ASEAN-based companies to move business, capital, and talent, which will in turn allow emerging businesses and markets to flourish.”In her opening presentation, Puan Azizah Mohd Yatim, CEO of CGS MY said, “This forum marks a major milestone in our ongoing efforts to attract more investment and trade to the region by leveraging CGS International Group’s Chinese parentage. Malaysia’s Chairmanship of ASEAN is happening at a unique time of a shifting world economy. Together with our fellow ASEAN members, we have a golden opportunity to co-ordinate and re-establish deeper, stronger intra-ASEAN, ASEAN+3 and global ties. Through our deep ASEAN network and parentage, we can connect and support the capital needs of businesses in the region and help investors navigate cross-border investments confidently. To date, we have organised and facilitated B2B and B2G engagements for companies and policymakers with China, working towards uplifting ASEAN’s businesses and economies.”On behalf of MBSB Group, its Chief Strategy Officer Dato’ Azlan Shahrim highlighted, “Our active participation in the ASEAN Business Forum reflects our commitment to catalysing deeper collaboration across the region. At MBSB Group, we are committed to advancing Malaysia’s regional and global ambitions through our unique combination of MBSB Bank’s banking solutions and MIDF’s development finance expertise. With focus on high-impact sectors such as renewable energy, electrical and electronics, aerospace, agri-foods, and halal, we provide bespoke services that empower businesses and SMEs to grow strategically across ASEAN and beyond. Through our investment banking services, Shariah advisory expertise, and commitment to sustainability, we are helping companies raise capital and scale, in line with the region’s evolving economic landscape.”Ms Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia, concluded, “At OCBC, we believe ASEAN’s strength lies in its connectivity — the seamless integration of markets, talent, and capital, underpinned by sustainable growth. Our participation in ABF2025 underscores our commitment to facilitate cross-border economic collaboration. Through OCBC Group’s integrated global network – spanning corporate & investment banking, private banking, asset management and insurance – we empower businesses to unlock growth opportunities that transcend borders. With our deep-rooted presence in ASEAN and Greater China, OCBC is uniquely positioned to deliver tailored sustainable and Islamic financial solutions as well as bespoke M&A advisory to facilitate trade and investment flows. Together, we are bridging economies while building a resilient, net-zero future for ASEAN.”The full-day forum will feature more than 20 speakers and panellists for discussions as well as closed- door meetings between investors and policy makers, all focused on addressing challenges and catalysing opportunities for high-value deals and strategic partnerships for regional economic growth. Several memoranda of understanding (MOUs) will be announced during the Forum, signalling long- term collaboration in strategic growth sectors such as healthcare, investments, single family office, and trade. In addition to the MOUs, China Galaxy Securities and CGS International Group intend to establish a China-Malaysia and ASEAN investment programme, which aims to foster capital flows, build stronger investment linkages, and support co-investment opportunities amongst China, Malaysia and ASEAN countries, with Malaysia as a key regional anchor. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
GMG Announces Internal G(R) Lubricant Testing Results Showing 10% Fuel Savings and 33% Reduction in Particulate Emissions ACN Newswire

GMG Announces Internal G(R) Lubricant Testing Results Showing 10% Fuel Savings and 33% Reduction in Particulate Emissions

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - May 27, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce the following internal GMG run engine test results when G® Lubricant was added to a Caterpillar 22 kVA diesel engine run at an 80% Load. Test results show a 10% increase in energy efficiency (kwh/litres), and also a 33% reduction in harmful diesel engine exhaust particulate matter emissions, when three doses of G® Lubricant, with a maximum graphene dosage of 0.03%, was added to the standard diesel engine oil.It is noted that the test engine was not operating optimally before G® Lubricant was added - the engine was overheating at long runs of sustained high loads. As a result, after the initial dose of G® Lubricant was added, an additional two dosages of G® Lubricant were used to hopefully bring the engine into a more stable operating regime, an outcome that was generally achieved.Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_gmg_image.jpgBuy Now at: www.G-Lubricant.com Figure 2 and 3 show the table and graph distribution of engine efficiency of the various dosages of G® Lubricant versus the baseline.Baseline Diesel Engine OilEngine Efficiency (kwh/litres)G® Lubricant (0.01%)Engine Efficiency (kwh/litres)G® Lubricant (0.02%)Engine Efficiency (kwh/litres)G® Lubricant (0.03%)Engine Efficiency (kwh/litres)3.043.36 (10% increase)3.35 (10% increase)3.36 (10% increase)Figure 2: Engine Efficiency Performance Increase from G® LubricantFigure 3: % Distribution of Fuel Efficiency Relative to BaselineTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_d626526a342c2ac9_005full.jpgFigures 4 and 5 show the table and graph distribution of diesel engine particulate matter emissions of the various dosages of G® Lubricant versus the baseline.Baseline Diesel Engine OilParticulate Matter (ppm)G® Lubricant (0.01%)Particulate Matter(ppm)G® Lubricant (0.02%)Particulate Matter (ppm)G® Lubricant (0.03%)Particulate Matter (ppm)20.9715.56 (26% reduction)14.55 (31% reduction)13.97 (33% reduction)Figure 4: Engine Emission Particulate Matter Reduction from G® LubricantFigure 5: % Distribution of Particulate Matter in Emissions Relative to BaselineTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/253490_d626526a342c2ac9_006full.jpgFigure 6 shows the exhaust emissions of the diesel engine at various dosages of G® Lubricant, versus the baseline which shows similar levels as the baseline test runs. More testing is being done to get more detail on the impact of G® Lubricant across engine emissions. % O2ppm COppm NO% CO2°C FTppm NOxppm NO2Baseline (DEO)7.8151.5359.69.830.0362.22.7DEO + 1% G® Lubricant7.5161.3383.510.028.1386.73.3DEO + 2% G® Lubricant7.5170.6377.010.027.6379.82.8DEO + 3% G® Lubricant7.4184.8388.710.128.4391.42.7Figure 6: Emissions Data for G® Lubricant Relative to BaselineDetailed Equipment and Process for Testing G® LubricantThe following describes the equipment used and the process followed by the Company in demonstrating the fuel saving demonstration of the G® Lubricant in the diesel engine generator:The same testing equipment, data systems and processes were used which was verified by the University of Queensland and detailed in GMG's previous press release on the 25th February, https://graphenemg.com/gmg-unveils-g-lubricant-engine-performance-testing-results-a-transformative-graphene-energy-saving-solution-for-the-multi-trillion-dollar-global-liquid-fuel-industry/GMG also added the following testing equipment to the testing program:Testo 340 Diesel Kit 2 engine emissions test kit which was newly calibrated by the third-party supplier.PDSA DPM-RT-2 particulate matter test unit which was newly calibrated by the third-party supplier.A 22kVA Caterpillar diesel engine generator (with 1,959 hours of run time) was setup in the GMG Richlands warehouse.The generator was connected to a 40-kW power load bank which consumed the energy produced by the generator and created the load and a 500-litre self-contained fuel tank.Two calibrated flow sensors were connected (inflow and return/outflow) to the fuel lines and to a data logger which recorded the fuel consumption.An Energy Analyzer was used to log and track energy produced by the generator.Tests were conducted on 80% loads of the engine from the 40-kW power load bank - 22 kW.A baseline to record diesel fuel consumption under normal engine oil and operating conditions was completed with newly changed recommended premium diesel engine oil and a new oil filter. This oil change was carried out by a professional engine maintenance service company.The engine was run at 80% load and the baseline and G® Lubricant data set used for the analytics is when the maximum ambient temperature for the day was less than 33 degrees Celsius and relative humidity was between 50% and 80% with no rain. Fuel consumption for diesel engines changes when operating in rain or very high humidity or temperatures, so the fuel consumption data baseline and G® Lubricant engine oil additive performance testing were excluded for these times.Only steady state data was used and so any variance or anomalous data seen in either baseline or G® Lubricant datasets were removed from the analytics. Data sets were grouped into minute blocks.Once the baseline fuel tests were completed, G® Lubricant with approximately 1:100 concentration was mixed at approximately 1% ratio by weight into the existing engine oil. This was done another 2 times. The end ratio of GMG's Graphene to the diesel engine oil was approximately 3:10,000 by weight.GMG's Managing Director and CEO, Craig Nicol, commented: "G® Lubricant is not only increasing fuel efficiency it is also reducing particulate matter - which is amazing to see - we will need to do more tests to see what the long-term performance is for this."GMG is continuing to conduct more tests to determine the total performance regime of the G® Lubricant. These performance tests will be announced as the information becomes available.GMG's Chairman and Director, Jack Perkowski, commented: "Fantastic news - G® Lubricant testing data are exciting - well done to the team - showing great promise as a way to reduce fuel costs and emissions across the multi-trillion dollar liquid fuels industry."About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the potential of G® Lubricant to optimize efficiency and power for stationary or mobile engines, the potential of G® Lubricant to reshape the future of the global liquid fuels industry, GMG's intention to commercialise and market G® Lubricant, the progress of the Company's patent applications, the potential market for G® Lubricant and the potential revenue available for G® Lubricant.Such forward-looking statements are based on a number of assumptions of management, including, without limitation that G® Lubricant has the potential to optimize efficiency and power for stationary or mobile engines, that G® Lubricant has the potential to reshape the future of the global liquid fuels industry, that GMG will commercialize and market G® Lubricant, that the Company's patent applications will progress as anticipated, and that the potential market and revenue available for G® Lubricant will be as currently forecasted. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that G® Lubricant will not offer an innovative solution that optimizes efficiency and power for stationary or mobile engines, that G® Lubricant will not reshape the future of the global liquid fuels industry, that GMG will commercialize and market G® Lubricant as anticipated, that the Company's patent applications will not progress as currently anticipated, that the potential market and revenue available for the G® Lubricant product is not as currently calculated, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/253490 Copyright 2025 ACN Newswire via SeaPRwire.com.
More

聯想控股旗下君聯資本及聯想之星共同投資企業派格生物醫藥在港交所成功上市

消息來源:聯想之星、君聯資本微信公眾號香港, 2025年5月27日 - (亞太商訊 via SeaPRwire.com) - 5月27日,聯想控股(3396.HK)旗下君聯資本及聯想之星共同投資的慢病創新藥企業派格生物醫藥(02565.HK)在香港聯交所成功上市。招股期間,派格生物醫藥香港公開發售認購額達到743.78倍。派格生物醫藥成立於2008年,是一家專注於自主研究及開發慢性病創新療法的生物技術公司,重點關注內分泌代謝領域。派格生物醫藥針對慢病領域未被滿足的臨床治療需求,利用自主開發的技術體系,設計和篩選具有「新靶標、新位點、新機制」的創新分子實體,形成優勢互補、多重獲益的產品管線。依靠高效及經驗豐富的研發團隊,通過自主研發,開發了一系列包括多肽藥物、蛋白質藥物及小分子藥物在內的優勢產品。派格生物醫藥構建了以代謝性疾病為核心,廣泛覆蓋多種慢病的研發管線,公司已自主開發一款核心產品及其他五款在研產品,以把握2型糖尿病(T2DM)、肥胖症、代謝功能障礙相關脂肪性肝炎(MASH)、阿片類藥物引起的便秘(OIC)及先天性高胰島素血症等常見慢病及代謝疾病的巨大市場機會。按照公司規劃,治療2型糖尿病的PB-119預計將於2025年上半年獲准在中國上市。這也意味著,派格生物醫藥即將成功實現商業化落地。作為創新藥企業,派格生物醫藥始終堅持自主研發,截至最後實際可行日期,公司擁有83項專利和專利申請,包括與核心產品有關的13項專利和15項專利申請,且所有重大專利及專利申請均為自有,臨床候選藥物均來自公司的HECTOR®平台及聚乙二醇(PEG)化技術。對此,聯想之星總裁、主管合伙人王明耀表示,「祝賀派格生物成功上市,聯想之星有幸長期陪伴並與其一路成長。在多年深耕中,派格生物最終做出令人驚嘆的國產創新好藥。憑借深厚積累和技術優勢,相信他們在生物醫藥行業能夠繼續創造出更大的價值。」聯想之星與派格生物結緣可追溯到2010年,當時聯想之星已經成立了當時國內最大的天使基金,並且將生物醫藥當作重點方向之一進行投資佈局。作為蘇州工業園區為發展生物醫藥產業而建立的專業科技創新載體 - 蘇州生物醫藥產業園,自然成為聯想之星重點關注的對象。巧合的是,派格生物剛好是最早一批入駐這個園區的企業。這家專注於慢性病創新療法的生物技術公司,正好符合聯想之星的投資主題。與派格生物接觸的過程中,聯想之星發現對方自主開發的GLP-1受體激動劑 - PB-119,不僅能治療2型糖尿病及肥胖症,而且與同類產品相比效果更好、成本更低。當時,僅中國的糖尿病患者人數就已經達到數千萬。有數據顯示,2021年,中國糖尿病發病人數就已超過400萬,患病總人數超過1.17億,死亡人數超過17.8萬。其中,2型糖尿病是最常見的糖尿病類型。更為重要的是,派格生物創始人徐敏擁有哥倫比亞大學生物物理學博士學位,並且在《科學》等期刊上共發表六篇文章,還曾經長期在中國生物醫藥行業做過風險投資和項目孵化,工作和管理經驗相當豐富。據聯想之星合伙人陸剛回憶,「不管是在藥物研發上的嚴謹和扎實,還是擁有非常清晰的商業意識,亦或是對市場競爭情況以及藥物未來市場定位的精准判斷,徐敏都給我們留下了深刻的印象。」再加上合適的價格,聯想之星很快便做出投資派格生物的決定。2011年,聯想之星在對方新一輪融資中投資了120萬美元,與此同時,派格生物也成為聯想之星真正意義上投資的第一個生物醫藥項目。三年後,這家公司不僅已經在國家十二五規劃「重大新藥創制」科技重大專項的政府支持下啓動PB-718的研發項目,而且這款產品還獲得I期臨床試驗的IND(新藥臨床試驗申請)批准。當派格生物需要資金支持時,聯想之星又及時伸出援手,果斷於2014年追加投資了對方100萬美元,讓派格生物成為自己的第一個追投項目。此外,除了通過整合中國科學院與聯想控股強大的導師和資源的「聯想之星創業CEO特訓班」幫助徐敏提升創業理念和管理能力,聯想之星還積極為派格生物對接君聯資本等投資方來解決對方發展所需的資金問題。隨著上市鐘聲的響起,聯想之星也在長期的陪伴中,獲得了13倍的投資回報。王明耀表示,聯想之星更加看重的是,派格生物不僅成功穿越了多個週期,最終還做出了令人驚嘆的國產創新好藥,「一方面,體現了聯想之星深耕生物醫藥行業的巨大價值;另一方面,這家公司的成功為生物醫藥行業提供了借鑒價值。」在聯想之星的積極對接之下,聯想控股旗下君聯資本亦於2014年、2016年兩次投資派格生物醫藥,一路支持公司發展。投資後,君聯資本在高管招聘、後續融資、BD合作等方面為派格生物醫藥提供了幫助。對於派格生物醫藥的成功上市,君聯資本表示祝賀,並認為公司從創立初期發展至今,實現了里程碑式的跨越。君聯資本表示,見證了公司在慢病創新藥研發領域的深耕與突破,此次成功登陸港交所不僅是市場對派格生物醫藥技術實力與長期價值的認可,更是中國創新藥發展的更進一步。公司看好派格生物醫藥上市後將進一步釋放產品及研發潛能,加速惠及全球患者。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
Ensign InfoSecurity Wins “Cybersecurity Product of the Year” at Tech Fest Hong Kong Awards ACN Newswire

Ensign InfoSecurity Wins “Cybersecurity Product of the Year” at Tech Fest Hong Kong Awards

AI-powered real-time deepfake detection solution, Aletheia, recognised for effectiveness, innovation, and operational scalabilityHONG KONG, May 27, 2025 - (ACN Newswire via SeaPRwire.com) - Ensign InfoSecurity (“Ensign”), one of Asia’s largest cybersecurity service providers, has won the “Product Excellence - Cybersecurity Product of the Year” award at the Tech Fest Hong Kong Awards 2025 for its proprietary solution, *Aletheia, an AI-powered real-time deepfake detection tool that enhances digital trust and protects organisations against multimedia-based deception.Developed by Ensign Labs, Aletheia uses multi-modal artificial intelligence to identify manipulated video and audio content. Available across endpoint software or a chrome browser plug-in, the solution delivers real-time detection to support secure virtual meetings, digital identity verification, and high-assurance communication environments.Built for operational environments, Aletheia performs all detection on-device, ensuring privacy-first analysis without cloud dependency. It integrates seamlessly with Security Information and Event Management (SIEM) systems to provide real-time alerts, enabling security teams to respond swiftly with forensic-ready evidence for investigation and resolution.“This award reinforces the purpose behind our work,” said Nicky Au, General Manager, Greater China Region, Ensign InfoSecurity (East Asia) Limited. “As threats grow more sophisticated, the ability to safeguard digital interactions, authentically and at speed, has become critical to business resilience and public trust.Cybersecurity is not achieved in isolation. It requires coordination, transparency, and shared intelligence. At Ensign, we are committed to working alongside our peers, partners, and clients to stay ahead of what’s next.”Aletheia is built to meet the evolving needs of sectors most vulnerable to digital deception. Examples of its use are varied. In financial services, it adds a line of defence during voice authentication and transaction validation. For media organisations, it supports source verification and editorial integrity. Government agencies can rely on it to validate emergency communications, while Human Resource departments use it to screen for audio-visual fraud in remote interviews and recruitment processes.This award underscores Ensign’s commitment to developing applied, scalable technologies through its in-house R&D. Aletheia is part of a broader portfolio of AI-powered capabilities that include cyber analytics, digital risk monitoring, and automated threat detection, designed to equip enterprises and public institutions with future-ready defence strategies.*Aletheia, in Greek mythology, refers to the Goddess of truth, symbolising the pursuit of truth and transparency.About Ensign InfoSecurityEnsign InfoSecurity is the largest cybersecurity service provider in Asia. Headquartered in Singapore, Ensign offers bespoke solutions and services to address their clients’ cybersecurity needs. Their core competencies are in the provision of cybersecurity advisory and assurance services, architecture design and systems integration services, and managed security services for advanced threat detection, threat hunting, and incident response. Underpinning these competencies is in-house research and development in cybersecurity. Ensign has two decades of proven track record as a trusted and relevant service provider, serving clients from the public and private sectors in the Asia Pacific region.For more information, visit www.ensigninfosecurity.com, or email media@ensigninfosecurity.com Copyright 2025 ACN Newswire via SeaPRwire.com.
More